Back to Top
Go Back
Journal Photo for Journal of Psychosomatic Research
Peer reviewed only Open Access

Journal of Psychosomatic Research (JPR)

Publisher : Elsevier Inc.
multidisciplinary psychology medicine
e-ISSN 1879-1360
p-ISSN 0022-3999
Issue Frequency Monthly
Impact Factor 3.5
Est. Year 1956
Mobile 12123098100
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email dc-support@elsevier.com

Journal Descriptions

Official Journal of the European Association of Psychosomatic Medicine and affiliated with the International College of Psychosomatic Medicine The Journal of Psychosomatic Research is a multidisciplinary research journal covering all aspects of the relationships between psychology and medicine. The scope is broad and ranges from basic human biological and psychological research to evaluations of treatment and services. Papers will normally be concerned with illness or patients rather than studies of healthy populations. Studies concerning special populations, such as the elderly and children and adolescents, are welcome. In addition to peer-reviewed original papers, the journal publishes editorials, reviews, and other papers related to the journal's aims. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Journal of Psychosomatic Research (JPR) is :-

  • International, Peer-Reviewed, Open Access, Refereed, multidisciplinary, psychology, medicine, illness, psychological research, human biological, Biological Psychiatry, Clinical Psychology, Psychiatry, Mental Health, Social Psychology , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0022-3999, E-ISSN: 1879-1360, Established: 1956, Impact Factor: 3.5
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of JPR

Mary P. Koss November, 2000
Objective: To assess the impact of treatment for co-morbid sleep-disordered breathing (SDB) on patients with nightmares and post-traumatic stress. Methods: Twenty-three chronic nightmare suf...